Ceperitus SRL
The score of Ceperitus shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ceperitus's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 01 Jul 2025
Ceperitus's financial analysis
- Solvency51.5%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ceperitus
Ceperitus's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0804.524.730
- VAT number
- BE0804524730
- Peppol
- Registered · 0208:0804524730 · as of 03 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Aug 2023
- Registered office
- 9000 Ghent
- Latest accounts
- 2024 · filed on 01 Jul 2025
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Ceperitus (SRL) has been based in Ghent since 2023, active in: research and experimental development on biotechnology. For 2024, it reports a net profit of 65,227 € and equity of 112,108 €; its revenue is not published. Its solvency stands at 51.5%, below the median of its sector (60.4%).
Companies similar to Ceperitus
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- GMPharm Research and experimental development on natural sciences and engineering Perwez · balance sheet 215,626 €
- STXC Research and experimental development on natural sciences and engineering Aalst · balance sheet 210,455 €
- TereLabs Research and experimental development on natural sciences and engineering Brussels · balance sheet 207,737 €
- Hephaistos-Belgium Research and experimental development on natural sciences and engineering Liège · balance sheet 242,189 €
- OCTIMET Oncology Research and experimental development on natural sciences and engineering Geel · balance sheet 252,753 €
- Arquebus Solutions Europe Research and experimental development on natural sciences and engineering Machelen (Brab.) · balance sheet 186,058 €
- Bayoclin Research and experimental development on natural sciences and engineering Nivelles · balance sheet 269,763 €
Frequently asked questions about Ceperitus
What is the revenue of Ceperitus?
Ceperitus files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Ceperitus?
In Belgium, the VAT number is the company number prefixed with BE: BE0804524730 for Ceperitus, if the company is VAT-registered. Its company number (CBE) is 0804.524.730.
Where is the registered office of Ceperitus?
According to the CBE register, the registered office of Ceperitus is in 9000 Ghent.
What is the equity of Ceperitus?
At the close of the 2024 financial year, the equity of Ceperitus amounts to 112,108 €, a solvency of 51.5% of total assets.
Who manages Ceperitus?
The register lists 1 active mandates at Ceperitus. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ceperitus
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →